Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 672 entries
View as:

Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03077412 Org: User:
Start: 04/06/17 End: 02/17/21 Due: 02/17/22

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04292899 Org: User:
Start: 03/06/20 End: 06/30/20 Due: 06/30/21

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02346721 Org: User:
Start: 02/23/15 End: 06/15/16 Due: 06/15/17

Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Phase: N/A Priority: Normal
NCT ID: NCT01987453 Org: User:
Start: 07/31/14 End: 11/30/15 Due: 11/30/16

A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT01271790 Org: User:
Start: 10/31/10 End: 09/30/13 Due: 09/30/14

Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT00874796 Org: User:
Start: 05/31/09 End: 07/31/10 Due: 07/31/11

Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels

Phase: N/A Priority: Normal
NCT ID: NCT05458102 Org: User:
Start: 08/19/22 End: 05/01/23 Due: 05/01/24

Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01687270 Org: User:
Start: 11/30/12 End: 08/31/14 Due: 08/31/15

Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)

Phase: N/A Priority: Normal
NCT ID: NCT03852433 Org: User:
Start: 05/31/19 End: 09/28/22 Due: 09/28/23

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Adults on Chronic Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT02600819 Org: User:
Start: 12/14/15 End: 10/15/19 Due: 10/15/20

Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT00701883 Org: User:
Start: 08/31/07 End: 08/31/08 Due: 08/31/09

Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Nosocomial Genotype 1 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01924949 Org: User:
Start: 07/31/13 End: 08/31/14 Due: 08/31/15

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa

Phase: N/A Priority: Normal
NCT ID: NCT00712166 Org: User:
Start: 05/31/08 End: 08/31/09 Due: 08/31/10

Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT04211909 Org: User:
Start: 01/03/20 End: 11/12/20 Due: 11/12/21

Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT02781584 Org: User:
Start: 06/13/16 End: 12/17/20 Due: 12/17/21

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa

Phase: N/A Priority: Normal
NCT ID: NCT00104520 Org: User:
Start: 02/28/05 End: 09/30/06 Due: 09/30/07

Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT02914522 Org: User:
Start: 11/14/16 End: 03/31/20 Due: 03/31/21

Safety Study of NHL With 90Y-hLL2 IgG

Phase: N/A Priority: Normal
NCT ID: NCT00421395 Org: User:
Start: 08/31/02 End: 10/31/07 Due: 10/31/08

GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT01353248 Org: User:
Start: 05/31/11 End: 03/31/13 Due: 03/31/14

PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00644761 Org: User:
Start: 02/29/04 End: 05/31/05 Due: 05/31/06

Safety and Efficacy of the Combination of Tirabrutinib and Entospletinib With and Without Obinutuzumab in Adults With Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT02983617 Org: User:
Start: 04/06/17 End: 10/01/20 Due: 10/01/21

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Japanese Adults With Chronic Genotype 2 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01910636 Org: User:
Start: 02/28/13 End: 06/30/14 Due: 06/30/15

Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3

Phase: N/A Priority: Normal
NCT ID: NCT02466516 Org: User:
Start: 06/08/15 End: 10/11/16 Due: 10/11/17

Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002450 Org: User:
Start: - End: - Due: -

Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02472886 Org: User:
Start: 06/17/15 End: 06/30/16 Due: 06/30/17